Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

 

Recent News and Articles on the Keywords: lymphoma + drug + skin  Related to the article below (Last Update: 8/5/2008)

Sceptic turns believer
Taranaki Daily News, New Zealand -
The study showed that infants given the probiotic had significantly less eczema during their second year and less reactivity to the skin prick test than ...
Bone Marrow Transplants: Cancer Drug Shows Promise Against Graft ...
Science Daily (press release) - Jul 10, 2008
Bone marrow stem cell transplants are most commonly used to treat leukemia and lymphoma. By replenishing depleted blood cells, the transplants allow higher ...
Xclair(R) Reported to Be Safe and Effective in Study Published in ...
FOXBusiness - Jul 8, 2008
Patients treated with Xclair demonstrated a statistically significant improvement compared to controls in maximum severity of skin toxicity (p less than ...CYCC
Chemo pill shows promise for advanced lymphoma
News-Medical.net, Australia - Jul 15, 2008
Doctors reported that the drug is halting disease in nearly half of the patients with two forms of lymphoma participating in early clinical trials in ...
Fish out of water with conspiracy theory
Brattleboro Reformer,  United States - Jul 31, 2008
There is leukemia and lymphoma; there is breast cancer; there is lung cancer; there is colon cancer; there is prostate, pancreatic and brain cancer. ...
FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions
PR Newswire (press release), NY - Jul 8, 2008
Lesions were characterized as one of the following choices: hepatocellular carcinoma, cholangiocarcinoma, metastasis, focal lymphoma, adenoma, focal nodular ...
Author Learns To Leave Well Enough Alone
NPR - Jul 7, 2008
I was used to being sick?by the time I started college, I'd already had skin cancer, meningitis, pancreatitis, and blood poisoning?but this was a whopper, ...

Natural News.com
Chemical Causes of Diabetes: Overeating Is Not the Only Problem
Natural News.com, AZ - Jul 24, 2008
IDDM is associated with a variety of hematologic changes (such as anemia) and malignancies (such as lymphocytic leukemia, lymphoma, and multiple myeloma) ...
Giving until it hurts
So Md News, MD - Jul 18, 2008
The life of someone he doesn?t know and might never meet; a man with non-Hodgkin?s lymphoma. When the Waldorf resident was in the US Navy he was asked to do ...
Pulmonary Langerhans Cell Histiocytosis and Other Pulmonary ...
RedOrbit, TX - Jul 16, 2008
35 Approximately half of Erdheim-Chester disease patients exhibit extraskeletal disease, including lung, heart, skin, kidney, retroperitoneum, retro-orbital ...
Source: Google News

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. -
R Edelson, C Berger, F Gasparro, B Jegasothy, P … - N Engl J Med, 1987 - ncbi.nlm.nih.gov
... of target lymphocytes, whereas the drug alone was inactive. Twenty-seven of 37 patients
with otherwise resistant cutaneous T-cell lymphoma responded to the ...

… depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report … -
RL Piekarz, R Robey, V Sandor, S Bakke, WH Wilson, … - Blood, 2001 - ncbi.nlm.nih.gov
Click here to read Inhibitor of histone deacetylation, depsipeptide (FR901228),
in the treatment of peripheral and cutaneous T-cell lymphoma: a case report. ...

… potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma … -
EC Vonderheid, ET Tan, AF Kantor, L Shrager, B … - J Am Acad Dermatol, 1989 - ncbi.nlm.nih.gov
... 8 or more years provides evidence that cutaneous T cell lymphoma can be ... systemic
cancers known to be induced by systemic administration of alkylating drugs. ...

Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. -
P Heald, A Rook, M Perez, B Wintroub, R Knobler, B … - J Am Acad Dermatol, 1992 - ncbi.nlm.nih.gov
Comment in: J Am Acad Dermatol. 1993 Jun;28(6):1023-4. Treatment of erythrodermic
cutaneous T-cell lymphoma with extracorporeal photochemotherapy. ...

… factor antagonist therapy and lymphoma development: Twenty-six cases reported to the Food and Drug … -
SL Brown, MH Greene, SK Gershon, ET Edwards, MM … - Arthritis & Rheumatism, 2002 - Mass Med Soc
... Citation(s): Brown SL et al. Tumor necrosis factor antagonist therapy and lymphoma
development: Twenty-six cases reported to the Food and Drug Administration. ...

Skin Cancers and Non-Hodgkin Lymphoma Among Users of Systemic Glucocorticoids: A Population-Based … -
HT Sorensen, L Mellemkjaer, GL Nielsen, JA Baron, … - jnci, 2004 - jnci.oxfordjournals.org
... in these other groups, use of immunosuppressive drugs is associated with increased
risks of non-melanoma skin cancers and non-Hodgkin lymphoma, although the ...

Topical carmustine (BCNU) for cutaneous T cell lymphoma: a 15-year experience in 143 patients.
HS Zackheim, EH Epstein Jr, WR Crain - J Am Acad Dermatol, 1990 - ncbi.nlm.nih.gov
J Am Acad Dermatol. 1990 May;22(5 Pt 1):802-10. Topical carmustine (BCNU) for
cutaneous T cell lymphoma: a 15-year experience in 143 patients. ...

Photopheresis therapy of cutaneous T-cell lymphoma: the Yale-New Haven Hospital experience.
PW Heald, MI Perez, I Christensen, N Dobbs, G … - Yale J Biol Med, 1989 - ncbi.nlm.nih.gov
... T-cell lymphoma. There were 19 erythrodermic patients who had photopheresis as their
first systemic therapy. Five of these cleared 75 percent of their skin and ...

Th2 Cytokine mRNA Expression in Skin in Cutaneous T-Cell Lymphoma. -
BR Vowels, SR Lessin, M Cassin, C Jaworsky, B … - Journal of Investigative Dermatology, 1994 - nature.com
... pattern with a malignant T-cell clone in different stages of cutaneous involvement
among patients with cutaneous T-cell lymphoma (CTCL). Skin biopsies were ...

… acitretin versus interferon-2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II … -
R Stadler, HG Otte, T Luger, BM Henz, P Kuhl, T … - Blood, 1998 - ncbi.nlm.nih.gov
... Cutaneous T-cell lymphoma (CTCL) constitutes a malignant proliferative disease
involving mostly CD4(+) T cells arising in the skin. ...

Source: Google Scholar

Skin Disorders Treated With Lymphoma Drug
A new review article from the journal Dermatologic Therapy reveals that rituximab, a drug used to treat lymphoma, is now becoming used by dermatologists to treat various dangerous skin diseases.

Originally developed as the standard therapy in treating aggressive lymphomas, the drug rituximab is showing increased non-cancer use. The study reviewed the off-label uses of rituximab in dermatology and found that it successfully treated patients with various kinds of blistering skin disease, including pemphigus vulgaris, dermatomyositis, and paraneoplastic pemphigus.

Newer, safer treatments are being studied for serious dermatologic disorders, and rituximab's efficacy has been shown in a variety of dangerous skin problems. "As case reports and randomized trials explore the utility of rituximab," the authors note, "the indications for rituximab will continue to be defined."


This study is published in the journal Dermatologic Therapy.

To view the abstract for this article, please click here.

Michael P. Heffernan, MD, is affiliated with Wright State University in Dayton, Ohio.

Dermatologic Therapy was created to fill an important void in the dermatologic literature: the lack of a readily available source of up-to-date information on the treatment of specific cutaneous diseases and the practical application of specific treatment modalities. The information contained in each issue is so practical and detailed that the reader should be able to directly apply various treatment approaches to daily clinical situations.

Wiley-Blackwell was formed in February 2007 as a result of the acquisition of Blackwell Publishing Ltd. by John Wiley & Sons, Inc., and its merger with Wiley's Scientific, Technical, and Medical business. Together, the companies have created a global publishing business with deep strength in every major academic and professional field. Wiley-Blackwell publishes approximately 1,400 scholarly peer-reviewed journals and an extensive collection of books with global appeal. For more information on Wiley-Blackwell, please visit http://www.blackwellpublishing.com/ or http://interscience.wiley.com/ .

Source: Amy Molnar
Blackwell Publishing Ltd.
 
 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
Continue News With: News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.